The Wall Street Journal
wsj.com
did:plc:i3fhjvvkbmirhyu4aeihhrnv
GSK withdrew its application for a drug touted last year by President Trump as a potential treatment for autism symptoms. https://on.wsj.com/4tIoPSt
2026-04-09T19:33:17.557Z
Enable JavaScript to use Bluesky.
Learn more about Bluesky at bsky.social and atproto.com.